Different haematopoietic growth factors have different capacity in overcoming the in vitro interferon gamma-induced suppression of bone marrow progenitor cells
- 24 April 2009
- journal article
- research article
- Published by Wiley in European Journal of Haematology
- Vol. 44 (5) , 282-290
- https://doi.org/10.1111/j.1600-0609.1990.tb00396.x
Abstract
Interferon gamma (IFN.gamma.) inhibits haematopoiesis in vitro and an in vivo role in bone marrow suppression has been implied from clinical studies. We investigated the capacity of three recombinant (r), human (h), haematopoietic growth factors to overcome the in vitro IFN.gamma. inhibition of bone marrow progenitor cells in a methylcellulose culture system. Granulocyte macrophage-colony stimulating factor (GM-CSF) partially reversed IFN.gamma.-induced suppression of granulocyte-macrophage colony formation, by increasing colony forming units-granulocyte macrophage (CFU-GM) in a proportion ranging from 54-101%. Interleukin-3 (IL-3) and granulocyte-colony stimulating factor (G-CSF) were much less effective. For erythropoiesis, IL-3 was much more effective and partially reversed IFN.gamma.-mediated inhibition by increasing burst forming units-erythroid (BFU-E) in a proportion ranging from 52-138%. GM-CSF and G-CSF had no significant effect on IFN.gamma.-induced suppression of BFU-E. In conclusion, haematopoietic growth factors have different capacity to overcome IFN.gamma.-induced suppression of marrow progenitor cells in vitro. The findings may have therapeutic implications, as combinations of growth factors may be more effective in treating bone marrow failure syndromes.Keywords
This publication has 35 references indexed in Scilit:
- Cyclosporine therapy of aplastic anaemia, congenital and acquired red cell aplasiaBritish Journal of Haematology, 1989
- In vitro interferon‐gamma production by cultured T‐cells in severe aplastic anaemia: correlation with granulomonopoietic inhibition in patients who respond to anti‐thymocyte globulinBritish Journal of Haematology, 1988
- Effect of Granulocyte Colony-Stimulating Factor on Neutropenia and Associated Morbidity Due to Chemotherapy for Transitional-Cell Carcinoma of the UrotheliumNew England Journal of Medicine, 1988
- Immunosuppressive treatment of aplastic anemia: a prospective, randomized multicenter trial evaluating antilymphocyte globulin (ALG) versus ALG and cyclosporin AAnnals of Hematology, 1988
- Lymphocyte phenotype and lymphokines following anti‐thymocyte globulin therapy in patients with aplastic anaemiaBritish Journal of Haematology, 1987
- Interferon‐induced aplasia: Evidence for t‐cell‐mediated suppression of hematopoiesis and recovery after treatment with horse antihuman thymocyte globulinAmerican Journal of Hematology, 1985
- Circulating Activated Suppressor T Lymphocytes in Aplastic AnemiaNew England Journal of Medicine, 1985
- Alpha Interferon for Induction of Remission in Hairy-Cell LeukemiaNew England Journal of Medicine, 1984
- Generation of CFU-C suppressor T cells in vitro: V. A. MULTISTEP PROCESSBritish Journal of Haematology, 1982
- TOXICITY OF HUMAN LEUCOCYTE INTERFERON PREPARATIONS IN HUMAN BONE-MARROW CULTURESThe Lancet, 1977